INVESTORS

    Company Information

    Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance to create effective, durable treatments for cancer patients.

    Stock Info

    Corporate Presentation

    Stock Chart

    Loading Events

    Upcoming Events

    Events Search and Views Navigation

    Event Views Navigation

    Press Releases

    SEC Filings

    Subscribe to updates

    Corporate Governance

    Purple Biotech Ltd.’s Board of Directors sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

    Corporate Governance Documents
    Code of Ethics Download
    Audit Committee Charter Download
    Compensation Committee Charter Download
    Audit Committee Compensation Committee
    Independent Directors
       Dr. Eric Rowinsky
       Revital Stern-Raff
       Ido Agmon
       Steven Steinberg
    Non-independent Directors
       Simcha Rock
       Isaac Israel
    Member   Chair